Radioembolization in liver tumors

Publication date: Available online 28 October 2019Source: Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)Author(s): L. Carrion-Martin, J. Orcajo Rincón, A. Rotger, M. Gonzalez-Leyte, L. Márquez Pérez, M. Echenagusia, A. MatillaAbstractThe detection of malignant liver tumours is recently increasing. These lesions have frequently arterial vascularization which differs from healthy parenchyma with main portal flow making them especially susceptible to transarterial therapies.Transarterial Radioembolization (TARE) is an emerging treatment for the management of different liver tumours. Significant improvements in the procedure have been made so it is considered a safe and effective treatment. A multidisciplinary approach is necessary because of the complexity of the procedure. An optimal selection of the patients and good planning arteriography are essential to obtain benefit and reduce complication rate.Although TARE has been used mostly in hepatocellular carcinoma and liver metastasis, indications are currently in expansion as the only treatment or in combination.ResumenLa enfermedad hepática tumoral es cada vez más frecuente. Su peculiar forma de irrigación, predominantemente arterial, a diferencia del resto del hígado con flujo fundamentalmente por vía portal, los hace susceptibles de terapias intraarteriales.La TARE o “Transartherial radioembolization” ha irrumpido con fuerza como tratamiento de tumores hepáticos de diferentes tipos. Si...
Source: Revista Espanola de Medicina Nuclear e Imagen Molecular - Category: Nuclear Medicine Source Type: research